We are live on ! Find out more
OWP

Old Well Partners Portfolio holdings

AUM $4.55M
1-Year Est. Return 27.75%
This Fund
S&P 500
This Quarter Est. Return
-5.95%
1 Year Est. Return
+27.75%
3 Year Est. Return
+97.85%
5 Year Est. Return
+345.65%
10 Year Est. Return
AUM
$194M
AUM Growth
-$26.6M
Cap. Flow
-$7.66M
Cap. Flow %
-3.95%
Top 10 Hldgs %
65.54%
Holding
52
New
13
Increased
9
Reduced
3
Closed
12

Top Buys

Rank Stock Value
1
ZTO icon
ZTO Express
ZTO
+$11.6M
2
TSM icon
TSMC
TSM
+$7.87M
3
VYGG
Vy Global Growth
VYGG
+$4.85M
4
STNE icon
StoneCo
STNE
+$3.49M
5
PDD icon
Pinduoduo
PDD
+$2.44M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.69%
2 Technology 25.2%
3 Healthcare 15.48%
4 Financials 10.95%
5 Industrials 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
26
Ascendis Pharma A/S
ASND
$16.6B
$215K 0.11%
+1,347
New +$184K
FRSH icon
27
Freshworks
FRSH
$2.99B
$213K 0.11%
+5,000
New +$224K
RNAM
28
DELISTED
Avidity Biosciences
RNAM
$211K 0.11%
+8,548
New +$186K
ANAB icon
29
AnaptysBio
ANAB
$1.59B
$210K 0.11%
7,737
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$206K 0.11%
12,711
-4,000
-24% -$43.5K
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$205K 0.11%
+1,160
New +$187K
RAIN
32
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$200K 0.1%
+13,383
New +$228K
TNGX icon
33
Tango Therapeutics
TNGX
$4.35B
$149K 0.08%
11,554
VYGG.WS
34
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$133K 0.07%
+98,914
New +$150K
FOLD
35
DELISTED
Amicus Therapeutics
FOLD
$113K 0.06%
+11,800
New +$121K
JYAC
36
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$113K 0.06%
11,547
ARYD
37
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$112K 0.06%
11,174
ATXS
38
DELISTED
Astria Therapeutics
ATXS
$107K 0.06%
+12,116
New +$116K
SLDB icon
39
Solid Biosciences
SLDB
$777M
$81K 0.04%
2,261
BCEL
40
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$62K 0.03%
10,023
ADVM
41
DELISTED
Adverum Biotechnologies
ADVM
-1,844
Closed -$65K
BABA icon
42
Alibaba
BABA
$276B
-43,800
Closed -$9.93M
BLFS icon
43
BioLife Solutions
BLFS
$1.46B
-5,668
Closed -$252K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.07T
-6,550
Closed -$1.82M
CPNG icon
45
Coupang
CPNG
$28.6B
-192,900
Closed -$8.07M
IGMS
46
DELISTED
IGM Biosciences
IGMS
-2,619
Closed -$218K
LX
47
LexinFintech Holdings
LX
$241M
-1,074,777
Closed -$13.2M
LOGC
48
DELISTED
ContextLogic
LOGC
-4,520
Closed -$1.79M
AGCB
49
DELISTED
Altimeter Growth Corp 2
AGCB
-18,258
Closed -$187K
VYGG.U
50
DELISTED
Vy Global Growth Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant to acquire one Class A Ordinary Share
VYGG.U
-494,573
Closed -$5.12M

Similar funds

Old Well Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Old Well Partners held 52 positions worth $194M, down 12% from $220M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Old Well Partners withdrew a net $7.66M in Q3 2021, closing 12 positions and reducing 3 holdings. Its most notable exit was LexinFintech Holdings, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 43% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Old Well Partners opened a new position in ZTO Express worth $12.4M.

  • Old Well Partners's largest Q3 2021 buy was ZTO Express: 403,800 shares worth $12.4M.
  • Old Well Partners added most to StoneCo in Q3 2021, an estimated $3.49M increase.
  • Old Well Partners's biggest Q3 2021 reduction was Sea Limited, cutting an estimated $5.28M.
  • Old Well Partners fully exited LexinFintech Holdings in Q3 2021, selling an estimated $13.2M.
  • Old Well Partners's ten largest holdings make up 66% of its $194M portfolio in Q3 2021.
  • Old Well Partners opened 13 new positions and closed 12 in Q3 2021.
  • Old Well Partners's portfolio value fell 12% quarter-over-quarter to $194M.

Based on Old Well Partners's 13F filing for Q3 2021, filed 15 Nov 2021.